These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27865890)

  • 1. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
    Gutman J; Kovacs S; Dorsey G; Stergachis A; Ter Kuile FO
    Lancet Infect Dis; 2017 Feb; 17(2):184-193. PubMed ID: 27865890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.
    Pons-Duran C; Wassenaar MJ; Yovo KE; Marín-Carballo C; Briand V; González R
    Cochrane Database Syst Rev; 2024 Sep; 9(9):CD006689. PubMed ID: 39324693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.
    Olaleye A; Okusanya BO; Oduwole O; Esu E; Meremikwu M
    Int J Gynaecol Obstet; 2019 Jul; 146(1):43-55. PubMed ID: 31050803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials.
    Muthoka EN; Usmael K; Embaye SM; Abebe A; Mesfin T; Kazembe D; Ahmedin M; Namuganza S; Kahabuka M; Atim MG; Manyazewal T
    Malar J; 2023 Oct; 22(1):320. PubMed ID: 37865784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
    Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
    Fernandes S; Were V; Gutman J; Dorsey G; Kakuru A; Desai M; Kariuki S; Kamya MR; Ter Kuile FO; Hanson K
    Lancet Glob Health; 2020 Dec; 8(12):e1512-e1523. PubMed ID: 33137287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
    González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
    Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
    Hughes E; Wallender E; Kajubi R; Jagannathan P; Ochieng T; Kakuru A; Kamya MR; Clark TD; Rosenthal PJ; Dorsey G; Aweeka F; Savic RM
    Clin Infect Dis; 2022 Aug; 75(3):406-415. PubMed ID: 34864925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
    Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
    Kakuru A; Jagannathan P; Muhindo MK; Natureeba P; Awori P; Nakalembe M; Opira B; Olwoch P; Ategeka J; Nayebare P; Clark TD; Feeney ME; Charlebois ED; Rizzuto G; Muehlenbachs A; Havlir DV; Kamya MR; Dorsey G
    N Engl J Med; 2016 Mar; 374(10):928-39. PubMed ID: 26962728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
    Saito M; Mansoor R; Kennon K; Anvikar AR; Ashley EA; Chandramohan D; Cohee LM; D'Alessandro U; Genton B; Gilder ME; Juma E; Kalilani-Phiri L; Kuepfer I; Laufer MK; Lwin KM; Meshnick SR; Mosha D; Mwapasa V; Mwebaza N; Nambozi M; Ndiaye JA; Nosten F; Nyunt M; Ogutu B; Parikh S; Paw MK; Phyo AP; Pimanpanarak M; Piola P; Rijken MJ; Sriprawat K; Tagbor HK; Tarning J; Tinto H; Valéa I; Valecha N; White NJ; Wiladphaingern J; Stepniewska K; McGready R; Guérin PJ
    Lancet Infect Dis; 2020 Aug; 20(8):943-952. PubMed ID: 32530424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
    PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.